(Q1)Mar 31, 2024 | |
---|---|
Operating Cash Flow (Indirect Method) | |
Cash flow from continuing operating activities | -934.68K |
Net income from continuing operations | ---1.4M |
Operating gains losses | --107.9K |
Depreciation and amortization | --185 |
Change In working capital | --242.19K |
-Change in prepaid assets | ---120.17K |
-Change in payables and accrued expense | --362.36K |
Cash from discontinued investing activities | |
Operating cash flow | ---934.68K |
Investing cash flow | |
Cash flow from continuing investing activities | -3.13K |
Net PPE purchase and sale | ---3.13K |
Cash from discontinued investing activities | |
Investing cash flow | ---3.13K |
Financing cash flow | |
Cash flow from continuing financing activities | 54.39K |
Net issuance payments of debt | ---23.82K |
Net common stock issuance | ---6K |
Net other financing activities | --84.21K |
Cash from discontinued financing activities | |
Financing cash flow | --54.39K |
Net cash flow | |
Beginning cash position | --1.27M |
Current changes in cash | ---883.43K |
End cash Position | --388.4K |
Free cash flow | ---937.81K |
Currency Unit | USD |
Accounting Standards | US-GAAP |
No Data
No Data